Skip to main content

Carisma Therapeutics Inc.

CARMDelisted Dec 15, 2025
Industry
Pharmaceutical Preparations
SEC CIK
0001485003

Carisma Therapeutics Inc. was delisted on Dec 15, 2025; its insiders filed their last Form 4 on Oct 8, 2025; 33 institutions reported holding it in 13F filings for Q3 2025, worth $842.6K in total; no superinvestor held it.

Q4 2023 vs. Q3 2023

How the institutions holding Carisma Therapeutics Inc. changed between Q3 2023 and Q4 2023.

All holders in Q4 2023All holders in Q3 2023

13F holders of CARM: Q3 2023 compared with Q4 2023
MeasureQ3 2023Q4 2023Change
Holders5850−8
Shares9.37M9.00M−368.0K (−3.9%)
Value$39.6M$26.4M−$13.3M (−33.5%)

New holders (3)

Institutions that held Carisma Therapeutics Inc. at the end of Q4 2023 but not at the end of Q3 2023.

Institutions new to CARM in Q4 2023
InstitutionSharesValue% of portfolio
Two Sigma Investments, LP25,393$74.4K0.00%
Susquehanna International Group, LLP10,062$29.5K0.00%
Signature Resources Capital Management, LLC14$410.00%

Sold out (11)

Institutions that held Carisma Therapeutics Inc. at the end of Q3 2023 and filed for Q4 2023 without it.